Hemodynamic effect of danazol therapy in women with uterine leiomyomata

Antonio La Marca; Maria Concetta Musacchio; Giuseppe Morgante; Felice Petraglia; Vincenzo De Leo

doi:10.1016/s0015-0282(03)00070-0

Hemodynamic effect of danazol therapy in women with uterine leiomyomata

Antonio La Marca, Maria Concetta Musacchio, Giuseppe Morgante, Felice Petraglia, Vincenzo De Leo

Fertility and sterility · 2003 · vol. 79(5) , pp. 1240–1242 · doi:10.1016/s0015-0282(03)00070-0 · PMID:12738528 · W2145519291

Other OA: bronze CC0 ⤵ 5 in-corpus citations

🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study investigated the impact of danazol therapy on blood flow within uterine leiomyomata in women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Danazol Estrogen Antagonists Hemodynamics Leiomyoma Uterine Neoplasms Adult Danazol Danazol Estrogen Antagonists Female Hemodynamics Humans Leiomyoma Leiomyoma Uterine Neoplasms Uterine Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

Altered uterine artery blood flow impedance after danazol therapy: possible mode of action in dysfunctional uterine bleeding via openalex
Danazol administration after gonadotrophin-releasing hormone analogue reduces rebound of uterine myomas via openalex
Danazol binding and translocation of steroid receptors via openalex
Danazol Inhibits Steroidogenesis via openalex
Short-term treatment of uterine fibromyomas with danazol via openalex
doi:10.1016/s0015-0282(16)59763-5 via openalex
doi:10.1016/s0015-0282(16)45789-4 via openalex
doi:10.1159/000291820 via openalex
doi:10.1016/s0002-9378(12)91826-8 via openalex
W2431724270 via openalex
doi:10.1016/s0002-9378(86)80016-3 via openalex
doi:10.1111/j.1471-0528.1992.tb13758.x via openalex
doi:10.1016/0002-9378(83)90463-5 via openalex
doi:10.1016/s0015-0282(16)43869-0 via openalex
doi:10.1210/jcem.76.2.8432797 via openalex
doi:10.1016/s0002-9378(94)70332-9 via openalex
doi:10.1016/0002-9378(66)90516-3 via openalex
doi:10.1016/0301-5629(92)90079-p via openalex

Cited by (3)

Source provenance

openalex: last seen: 2026-05-11T04:53:08.733209+00:00
pubmed: last seen: 2026-10-08T21:00:58.458861+00:00

License: CC0 · commercial use OK

[1] Altered uterine artery blood flow impedance after danazol therapy: possible mode of action in dysfunctional uterine bleeding via openalex

[2] Danazol administration after gonadotrophin-releasing hormone analogue reduces rebound of uterine myomas via openalex

[3] Danazol binding and translocation of steroid receptors via openalex

[4] Danazol Inhibits Steroidogenesis via openalex

[5] Short-term treatment of uterine fibromyomas with danazol via openalex

[6] doi:10.1016/s0015-0282(16)59763-5 via openalex

[7] doi:10.1016/s0015-0282(16)45789-4 via openalex

[8] doi:10.1159/000291820 via openalex

[9] doi:10.1016/s0002-9378(12)91826-8 via openalex

[10] W2431724270 via openalex

[11] doi:10.1016/s0002-9378(86)80016-3 via openalex

[12] doi:10.1111/j.1471-0528.1992.tb13758.x via openalex

[13] doi:10.1016/0002-9378(83)90463-5 via openalex

[14] doi:10.1016/s0015-0282(16)43869-0 via openalex

[15] doi:10.1210/jcem.76.2.8432797 via openalex

[16] doi:10.1016/s0002-9378(94)70332-9 via openalex

[17] doi:10.1016/0002-9378(66)90516-3 via openalex

[18] doi:10.1016/0301-5629(92)90079-p via openalex